Monster Beverage Corporation · MNST · FY2026 Q2 · Calendar Q3 2026
Monster Beverage posts record Q2 sales as international growth stays strong
The quarter supports a constructive but qualified view of Monster Beverage's growth trajectory: record sales, international momentum, and product innovation remain supportive, while cost inflation, pricing execution, and the durability of recent share gains are the main tests.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about MNST FY2026 Q2
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, management described another record sales quarter, with growth broadening through international markets, expanded marketing and partnerships, and a fuller innovation pipeline. The call also highlighted a planned stock split, upcoming U.S. pricing actions, and continued tariff and freight-cost pressure.
Guidance delta
No formal guidance change was provided. Management discussed selective U.S. pricing actions planned for the fourth quarter and continued product, distribution, and digital-transformation initiatives.
Key takeaways
- Q2 net sales increased 20% year over year to $2.54 billion, with the Monster Energy segment up 21.6%.
- International sales grew more than 30%, with management highlighting momentum across LATAM, EMEA, and APAC.
- Management emphasized zero-sugar products, expanded marketing, and Coca-Cola bottling-system partnerships as growth supports.
- Aluminum tariff and freight costs remain margin considerations, while the innovation calendar and U.S. pricing actions are upcoming watch points.
Management priorities
- Sustain international growth and distribution expansion.
- Extend the zero-sugar and broader innovation pipeline, including upcoming NACS Show launches.
- Expand FSOP access through partnerships, including Marriott.
- Execute the SAP S/4HANA digital transformation targeted for January 2028.
Follow MNST with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Sep 22, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Neutral | Neutral | Maintain | Aug 7, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 7, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Aug 7, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Aug 7, 2026 |
| Deutsche Bank | Hold | Buy | Downgrade | Jul 20, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 20, 2026 |
| Stifel | Buy | Buy | Maintain | Jul 16, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 14, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 8, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jun 1, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | May 8, 2026 |
| Rothschild & Co | Buy | Neutral | Upgrade | May 6, 2026 |
| TD Cowen | Hold | Hold | Maintain | Jan 8, 2026 |
| B of A Securities | Buy | Buy | Maintain | Nov 7, 2025 |
| Roth Capital | Neutral | Neutral | Maintain | Aug 13, 2025 |
| Redburn Atlantic | Neutral | Buy | Downgrade | Jul 9, 2025 |
| Roth MKM | Neutral | Neutral | Maintain | May 14, 2025 |
| CICC | Outperform | Market Perform | Upgrade | May 12, 2025 |
| Truist Securities | Sell | Sell | Maintain | Apr 24, 2025 |
| Needham | Hold | Hold | Maintain | Feb 28, 2025 |
| HSBC | Buy | Buy | Maintain | Mar 6, 2024 |
| MKM Partners | Neutral | Neutral | Maintain | Aug 10, 2023 |
| Goldman Sachs | Buy | Buy | Maintain | May 5, 2023 |
| Wedbush | Neutral | Neutral | Maintain | Mar 30, 2023 |
| Argus Research | Buy | Buy | Maintain | Mar 21, 2023 |
| Redburn Partners | Buy | Neutral | Upgrade | Mar 6, 2023 |
| Bernstein | Outperform | Market Perform | Upgrade | May 18, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Feb 18, 2022 |
| Jefferies | Hold | Buy | Downgrade | Oct 13, 2021 |
| Guggenheim | Buy | Neutral | Upgrade | Mar 20, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Feb 28, 2020 |
| Cowen & Co. | Market Perform | Outperform | Downgrade | Oct 17, 2019 |
| Macquarie | Neutral | Outperform | Downgrade | Apr 1, 2019 |
| Stifel Nicolaus | Buy | Buy | Maintain | Sep 18, 2018 |
| Susquehanna | Negative | Neutral | Downgrade | Nov 20, 2017 |
| Bank of America | Neutral | Neutral | Maintain | Mar 22, 2016 |
| CLSA | Buy | Outperform | Maintain | Feb 26, 2016 |
| ISI Group | Buy | Buy | Maintain | Sep 22, 2014 |
| Longbow Research | Neutral | Underperform | Upgrade | Aug 8, 2014 |
| BTIG Research | Buy | Buy | Maintain | Jun 19, 2014 |
| Northcoast Research | Sell | Sell | Maintain | Aug 23, 2013 |
| Gabelli & Co. | Hold | Buy | Downgrade | May 9, 2013 |
| ValuEngine | Strong Buy | Strong Buy | Maintain | Nov 27, 2012 |
| Canaccord Genuity | Hold | Hold | Maintain | May 10, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $44. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Deutsche Bank | Analyst unavailable | $100 | $90.36 | +127.3% | Aug 10, 2026 |
| RBC Capital | Nik Modi | $97 | $94.65 | +120.5% | Aug 5, 2026 |
| BMO Capital | Andrew Strelzik | $95 | $97.5 | +115.9% | Jul 20, 2026 |
| Deutsche Bank | Steve Powers | $98 | $97.5 | +122.7% | Jul 20, 2026 |
| UBS | Analyst unavailable | $104 | $99.59 | +136.4% | Jul 16, 2026 |
| Wells Fargo | Chris Carey | $105 | $96.92 | +138.6% | Jul 8, 2026 |
| Bernstein | Analyst unavailable | $95 | $92.03 | +115.9% | Jun 11, 2026 |
| Morgan Stanley | Dara Mohsenian | $103 | $88.08 | +134.1% | Jun 1, 2026 |
| Morgan Stanley | Analyst unavailable | $100 | $86.29 | +127.3% | May 10, 2026 |
| Evercore ISI | Analyst unavailable | $95 | $85.84 | +115.9% | May 8, 2026 |
| Redburn Partners | Charlie Higgs | $90 | $75.8 | +104.5% | May 6, 2026 |
| RBC Capital | Analyst unavailable | $86 | $76.19 | +95.5% | Apr 9, 2026 |
| Jefferies | Analyst unavailable | $100 | $77.52 | +127.3% | Mar 11, 2026 |
| Seaport Global | Analyst unavailable | $88 | $85.3 | +100.0% | Feb 27, 2026 |
| RBC Capital | Analyst unavailable | $88 | $84.76 | +100.0% | Feb 24, 2026 |
| Deutsche Bank | Analyst unavailable | $88 | $83.22 | +100.0% | Feb 20, 2026 |
| Argus Research | Analyst unavailable | $95 | $81.42 | +115.9% | Jan 27, 2026 |
| Morgan Stanley | Analyst unavailable | $96 | $82 | +118.2% | Jan 26, 2026 |
| BNP Paribas | Analyst unavailable | $77 | $77.91 | +75.0% | Jan 16, 2026 |
| UBS | Peter Grom | $84 | $76.95 | +90.9% | Jan 14, 2026 |
| Wells Fargo | Chris Carey | $86 | $75.75 | +95.5% | Jan 5, 2026 |
| Morgan Stanley | Analyst unavailable | $87 | $77.66 | +97.7% | Dec 23, 2025 |
| Stifel Nicolaus | Matthew Smith | $82 | $72.49 | +86.4% | Dec 12, 2025 |
| Roth Capital | Analyst unavailable | $70 | $73.98 | +59.1% | Dec 3, 2025 |
| BMO Capital | Andrew Strelzik | $73 | $74.71 | +65.9% | Dec 3, 2025 |
| Piper Sandler | Michael Lavery | $85 | $74.71 | +93.2% | Dec 3, 2025 |
| Wells Fargo | Chris Carey | $83 | $74.71 | +88.6% | Dec 3, 2025 |
| RBC Capital | Nik Modi | $81 | $74.99 | +84.1% | Dec 1, 2025 |
| Morgan Stanley | Dara Mohsenian | $81 | $72.28 | +84.1% | Nov 7, 2025 |
| Jefferies | Kaumil Gajrawala | $79 | $66.48 | +79.5% | Nov 4, 2025 |
| Stifel Nicolaus | Matthew Smith | $78 | $69.52 | +77.3% | Oct 24, 2025 |
| RBC Capital | Nik Modi | $75 | $69.57 | +70.5% | Oct 10, 2025 |
| UBS | Analyst unavailable | $72 | $68.15 | +63.6% | Oct 8, 2025 |
| RBC Capital | Nik Modi | $68 | $65.26 | +54.5% | Aug 8, 2025 |
| Wells Fargo | Chris Carey | $73 | $60.8 | +65.9% | Aug 8, 2025 |
| Piper Sandler | Michael Lavery | $74 | $64.69 | +68.2% | Aug 8, 2025 |
| Morgan Stanley | Dara Mohsenian | $70 | $63.69 | +59.1% | Jun 12, 2025 |
| Goldman Sachs | Bonnie Herzog | $67 | $62.87 | +52.3% | May 23, 2025 |
| UBS | Analyst unavailable | $57 | $54.65 | +29.5% | Mar 2, 2025 |
| Morgan Stanley | Analyst unavailable | $60 | $54.65 | +36.4% | Feb 28, 2025 |
| Deutsche Bank | Steve Powers | $61 | $52.3 | +38.6% | Nov 1, 2024 |
| Goldman Sachs | Bonnie Herzog | $63 | $45.26 | +43.2% | Aug 8, 2024 |
| BMO Capital | Andrew Strelzik | $54 | $45.32 | +22.7% | Aug 8, 2024 |
| Piper Sandler | Michael Lavery | $46 | $44.2 | +4.5% | Aug 8, 2024 |
| Jefferies | Kaumil Gajrawala | $60 | $50.53 | +36.4% | Aug 8, 2024 |
| RBC Capital | Nik Modi | $64 | $49.95 | +45.5% | Jul 1, 2024 |
| BNP Paribas | Kevin Grundy | $48 | $49.09 | +9.1% | Jun 24, 2024 |
| RBC Capital | Nik Modi | $65 | $48.52 | +47.7% | Jun 14, 2024 |
| Goldman Sachs | Bonnie Herzog | $66 | $48.72 | +50.0% | Jun 14, 2024 |
| Deutsche Bank | Steve Powers | $63 | $48.72 | +43.2% | Jun 14, 2024 |
| Jefferies | Kaumil Gajrawala | $61 | $49.77 | +38.6% | Jun 13, 2024 |
| Roth Capital | Sean McGowan | $56 | $51.16 | +27.3% | Jun 12, 2024 |
| BMO Capital | Andrew Strelzik | $56 | $54.86 | +27.3% | May 3, 2024 |
| Piper Sandler | Michael Lavery | $59 | $54.52 | +34.1% | May 3, 2024 |
| Truist Financial | Bill Chappell | $46 | $54.33 | +4.5% | Apr 25, 2024 |
| Piper Sandler | Michael Lavery | $50 | $50.3 | +13.6% | Oct 24, 2023 |
| Wedbush | Gerald Pascarelli | $23.75 | $22.76 | -46.0% | Oct 10, 2022 |
| UBS | Peter Grom | $24.75 | $22.54 | -43.8% | Aug 24, 2022 |
| Roth Capital | Sean McGowan | $25 | $24.35 | -43.2% | Jul 13, 2022 |
| Stifel Nicolaus | Mark Astrachan | $26.25 | $22.96 | -40.3% | Jun 23, 2022 |
| Morgan Stanley | Dara Mohsenian | $29.25 | $22.03 | -33.5% | Jun 18, 2022 |
| RBC Capital | Nik Modi | $25 | $22 | -43.2% | Jun 14, 2022 |
| Bernstein | Callum Elliott | $27.5 | $22.31 | -37.5% | May 18, 2022 |
| Stifel Nicolaus | Mark Astrachan | $25.75 | $18.3 | -41.5% | Mar 13, 2022 |
| Citigroup | Wendy Nicholson | $24.5 | $21.14 | -44.3% | Feb 25, 2022 |
| Credit Suisse | Kaumil Gajrawala | $27.5 | $20.32 | -37.5% | Feb 18, 2022 |
| Wells Fargo | Chris Carey | $25 | $20.81 | -43.2% | Feb 16, 2022 |
| Goldman Sachs | Bonnie Herzog | $27.25 | $24.44 | -38.1% | Jan 4, 2022 |
| Morgan Stanley | Dara Mohsenian | $27.75 | $22.91 | -36.9% | Nov 5, 2021 |
| Jefferies | Kevin Grundy | $23 | $21.33 | -47.7% | Oct 13, 2021 |
| Truist Financial | Bill Chappell | $28.75 | $22.81 | -34.7% | May 7, 2021 |
Track every rating change on MNST the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationMonster Beverage Corporation is a global entity primarily involved in the innovation, marketing, sale, and distribution of energy beverages and concentrates. Its business operations are categorized into three main divisions: Monster Energy Drinks, Strategic Brands, and a segment designated as "Other." The company boasts an extensive product portfolio, encompassing a wide array of carbonated energy drinks, alongside various non-carbonated options. These include ready-to-drink iced teas, lemonades, diverse juice cocktails, single-serving juices, and fruit beverages. Additionally, their offerings extend to ready-to-drink dairy and coffee-based concoctions, specialized sports drinks, single-serve still waters, and a selection of sodas described as natural, sparkling juices, and flavored sparkling beverages. Monster Beverage distributes its products through a comprehensive network, supplying bottlers and full-service beverage distributors.…
Historical context
All MNST earningsConsumer Defensive peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| KR The Kroger Co. | FY2026 Q2 · Calendar Q3 2026 | +2.8% | +2.7% | Kroger: Strong digital growth offsets softer sales outlook |
| CPB Campbell Soup Company | FY2026 Q4 · Calendar Q3 2026 | +1.1% | -7.0% | Campbell’s leans on savings and innovation amid pressured demand |
| BF-A Brown-Forman Corporation | FY2027 Q1 · Calendar Q3 2026 | +3.0% | — | Brown-Forman holds FY27 outlook as RTD innovation offsets barrel pressure |
| BF-B Brown-Forman Corporation | FY2027 Q1 · Calendar Q3 2026 | 0.0% | — | Brown-Forman maintains FY27 outlook as innovation offsets pressure |
| DG Dollar General Corporation | FY2027 Q2 · Calendar Q3 2026 | +23.4% | +2.5% | Dollar General Raises FY2026 Outlook After Strong Q2 |
| DLTR Dollar Tree, Inc. | FY2027 Q2 · Calendar Q3 2026 | +134.8% | -3.9% | Dollar Tree: Strong Q2 execution, but guidance held steady |
Latest beats and misses
Who reports nextBeat on EPS
- FPSFY2026 Q4 · September 15, 2026+4.3% EPS+9.5% move
- TCOMFY2026 Q2 · September 15, 2026+22.3% EPS+3.0% move
- KRFY2026 Q2 · September 11, 2026+2.8% EPS+2.7% move
- ADBEFY2026 Q3 · September 10, 2026+0.8% EPS+1.4% move
- ORCLFY2027 Q1 · September 10, 2026+10.3% EPS-1.7% move
- CASYFY2027 Q1 · September 8, 2026+8.7% EPS-14.2% move
Get the MNST recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-08-07T18:19:40.255731+00:00
- FN2 earnings calendar · 2026-09-11T01:23:15.000588+00:00
- Polygon adjusted daily market bars · 2026-09-22T09:00:54.522085+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-22T09:00:54.519161+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.